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The study of interactions between microorganisms and
higher cells or, more generally, between microbiology
and immunology, originated with the beginning of these
scientiﬁc ﬁelds. In fact, the development of immunology
as a scientiﬁc discipline was a logical consequence of the
germ theory of disease. In the mid-nineteenth century,
remarkable contributions were made by the French and
German schools, which approached immunology and
bacteriology as a single scientiﬁc discipline, and which
had in Pasteur and Koch, respectively, their most out-
standing representatives. We must also remember that it
was the confrontation between these two schools that
led to the splitting of immunology into two branch-
es—humoral and cell-mediated—, a separation that is
still maintained.
Due to the increasing amount of knowledge and the
rapid advancements in microbiology and immunology,
as well as in microbial ecology, it has become widely
accepted that, during evolution, the cells of multicellular
organisms have established essential relationships with
many prokaryotic and lower eukaryotic organisms, with
which they coexist. This suggests an exquisite balance
between the elimination of microorganisms by the im-
mune system and the spread and growth of colonizing
microorganisms. Nevertheless, there are many other
organisms—prokaryotes, eukaryotes, and virus-
es—against which multicellular organisms orchestrate a
defensive response aimed at their elimination from areas
that must be kept aseptic. Regarding pathogenic mi-
croorganisms, there must be also a balance between
colonization and keeping the host alive, since the host’s
death would imply the pathogen’s death too.
The incidence of infectious diseases has greatly in-
creased over the last two decades. One reason for this is
the renewed increase in the occurrence of microorgan-
isms responsible for diseases, such as tuberculosis, which
in the past had been nearly eliminated by antibiotics. In
addition, there is a higher incidence of infections sub-
sequent to transitory immunodeﬁciencies such as those
caused by extremely invasive medical procedures, in-
cluding anticancer therapies, the general use of broad-
spectrum antibiotics, the enormous development of or-
gan transplantation, and the emergence of virus-induced
diseases that cripple the immune system, e.g. AIDS.
Consequently, some microorganisms that are usually
harmless commensals have the potential of becoming
opportunistic pathogens; this is the case of Candida
albicans, which is responsible for both surface and sys-
temic infections. The occurrence of other microorgan-
isms, including the ﬁlamentous fungus Aspergillus
fumigatus, which causes hemorrhagic fever, has also
drastically increased. Finally, external phenomena in-
cluding climatic change, the invasion by humans of new
geographical areas and niches, and human migration all
present new challenges for the human immune system.
Eﬀorts to help the immune system to overcome the
challenges posed by ‘‘modern times’’ have mainly been
focused along two lines of research: (1) an intensive
screening for new drugs to more eﬀectively control
emerging infectious diseases; and (2) attempts to identify
the mechanisms by which the immune system controls
the occurrence of pathogenic microorganisms. The study
of cellular targets for new antimicrobial agents has led to
the production of very selective drugs with fewer side
eﬀects on host cells. New anti-AIDS drugs allow AIDS
patients to have acceptable life expectancies and quality
of life, at least in developed countries. Three types of
clinical trials of an AIDS vaccine have been carried out
in Thailand and the USA; the results should soon be
available. However, assays with monkeys vaccinated
against AIDS have shown that the vaccines are palliative
rather than protective, decelerating the progression of
AIDS but not conferring immunity against the disease.
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Vaccinated monkeys become infected but AIDS pro-
ceeds at a slower pace. New antifungal agents—now in
the last steps of clinical trials—disrupt structures of
fungal cell walls. Great eﬀorts have also been made
to design new methods and protocols that allow early
diagnosis of these infections.
Regarding the mechanisms employed by the immune
system to ﬁght diﬀerent kinds of infections, much has
been learned about the modulation of the TH1/TH2
response by helper-T-lymphocytes. It is the outcome of
this response that determines the susceptibility or resis-
tance of the host to a given microorganism. The studies
carried out in C. albicans provide an example. C. albi-
cans exhibits a dimorphic transition from yeast to a
mycelium, the latter being the infectious agent. It has
been increasingly accepted that as a single-celled yeast
C. albicans induces a TH1 (cell-mediated) response that
eﬃciently controls if not eliminates the infection. When
C. albicans grows as a mycelium, however, it ‘‘hides’’
from the TH1 protective response and induces a TH2
(humoral) response which is not eﬃcient against
C. albicans infection. The C. albicans model exempliﬁes
how an understanding of immune system processes can
help us to modulate them externally by using the
appropriate drugs and thereby lead or assist the immune
system in coping with the challenges that ‘‘modern
times’’ present.
At this moment, the new ﬁelds of genomics and
proteomics merit some attention. The sequencing of
whole genomes and the study of their protein maps have
generated an amazing amount of information not only
about microorganisms but also about higher organisms.
These areas of research have provided us with powerful
tools for better understanding the structure, function,
and biology of both microorganisms and immune sys-
tems.
We cannot end this discussion without mentioning
the eﬀorts also made in vaccine research. Current trends
include the use of recombinant vaccines, live viral vec-
tors, conjugated vaccines, DNA vaccines, and anti-tu-
moral vaccines. Much of this research tries to solve
limitations of traditional vaccines, both economical and
those related to preservation and distribution, which
have prevented their use in some geographical regions.
New protocols for vaccine administration, including
nasal, vaginal, and skin patches, along with new strate-
gies for vaccination, oﬀer a promising future.
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